Findings of a new study released last month (January 2022) show that palmitoylethanolamide (PEA) when used in combination with phycocyanin (PC), protects infected and inflamed epithelial cells from both the lungs and the prostate from cytotoxicity. The PEA and PC combination also greatly “abated both the production of radical oxygen species (ROS) and the transcription…
What Patients & Practitioners Are Saying
About Our Compounding Medicines